Fujifilm Validates Novel Peptide-Oligonucleotide Conjugates for Targeted Cancer Cell Delivery
Fujifilm has successfully validated peptide-oligonucleotide conjugates that selectively target cancer cells, utilizing cyclic peptides from their proprietary library containing trillions of variants.
© Copyright 2025. All Rights Reserved by MedPath